IDH-mutant glioma: A new IDH1 inhibitor moves forward

Neuro Oncol. 2023 Feb 14;25(2):337-338. doi: 10.1093/neuonc/noac275.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Brain / metabolism
  • Enzyme Inhibitors
  • Glioma* / drug therapy
  • Glioma* / genetics
  • Humans
  • Isocitrate Dehydrogenase / genetics
  • Isocitrate Dehydrogenase / metabolism

Substances

  • Enzyme Inhibitors
  • IDH1 protein, human
  • Isocitrate Dehydrogenase